Navigation Links
Ten-Year Follow-Up by AGH Doctors Confirms Effectiveness of Less-Invasive Surgery for Women With Early Stage Breast Cancer
Date:6/3/2013

Chicago, IL (PRWEB) June 03, 2013

A less invasive technique called sentinel node resection is as safe and effective as traditional surgery of removing all lymph nodes from the underarm area for women with breast cancer, according to a new study being presented today at the American Society of Clinical Oncology (ASCO) meeting by oncologists from the National Surgical Adjuvant Breast and Bowel Project (NSABP) and Allegheny General Hospital (AGH) in Pittsburgh.

The 10-year follow up of the largest-ever Phase III trial comparing the two methods’ effect on breast cancer survival and recurrence shows no significant difference in overall survival or disease-free survival, said Thomas Julian, MD, Associate Director of the Breast Care Center at AGH and one of the clinical trial’s principal investigators, along with Norman Wolmark, MD, a surgical oncologist at AGH who serves as Chair of the NSABP. Dr. Julian presented the trial results this morning at the annual ASCO meeting in Chicago.

“Removal of lymph nodes can result in painful complications for women with breast cancer,” Dr. Julian said. “This 10-year follow-up shows that women with node-negative breast cancer, the most common kind, can feel confident that a less-invasive sentinel node resection is equally effective and safe. Sentinel node resection is clearly the standard of care for these women.”

Each year, more than 200,000 women in the United States are diagnosed with breast cancer, and almost 40,000 will die from it. With early detection, the five-year survival rate is as high as 90 percent.

The study enrolled 5,611 women with invasive breast cancer over a period of five years and randomly assigned them to sentinel node resection alone or sentinel node resection plus complete axillary dissection of the lymph nodes. Ten years after their surgeries, the researchers continued to find no significant difference between the two groups of women in overall and disease-free survival. Additionally, the use of special stains to find occult tumor cells in the lymph nodes offers no additional benefit for the patient.

Removing all lymph nodes from the underarm area carries the risk of difficult and sometimes permanent complications, including lost sensation in the back of the arm, tingling, weakness and swelling (lymphedema).

Sentinel nodes are normally the first lymph nodes to receive drainage as well as cancer cells from the breast tumor. Doctors can find the sentinel nodes and remove them with a small surgical procedure. If no cancer is found, removal of the remaining lymph nodes is not necessary.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10790125.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bridges to Recovery Reaches Ten-Year Milestone as Premiere, Licensed Residential Behavioral Treatment Program and Honors Founding Medical Director Dr. Terry V. Eagan
2. New York City successfully locates HIV-positive patients lost to follow-up
3. Nephrologist follow-up improves mortality of severe acute kidney injury patients
4. Chernobyl follow-up study finds high survival rate among young thyroid cancer patients
5. Follow-Up Care After Chest Pain Called Crucial
6. Evidence shows concussions require long-term follow-up for players
7. 5-year follow-up - over half of all ACL reconstructions could be avoided
8. Less than half of youth with mental illness received adequate follow-up care, new study finds
9. A Viagra follow-up? Drug used to treat glaucoma actually grows human hair
10. Missing Follow-Up Colonoscopies Could Raise Colon Cancer Risk
11. Medical follow-up in celiac disease is less than optimal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... NY (PRWEB) , ... December 03, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted its first Swirl: A Wine Tasting Event in New York City, ...
(Date:12/4/2016)... ... December 03, 2016 , ... Houston ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... ... undergoing major cosmetic surgery can now take advantage of a cosmetic procedure known ... skin rejuvenation treatment that reduces the appearance of age spots, fine lines, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with ... preventative dental services to more than 15,900 children 5 years old and younger and ... $38 million over a span of five years to Western University of Health Sciences, ...
(Date:12/2/2016)... ... 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host the ... the 2016 MPN Heroes—eight individuals who have made a difference in the field of ... standard of care, demonstrating leadership within the MPN community and/or a commitment to individual ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)... -- Sickle cell disease (SCD) is an inherited chronic ... get stuck in veins and block blood flow, which ... leading to death. Each year, approximately 300,000 people around ... them lack access to comprehensive care or effective treatment ... SCD, a pill called hydroxyurea approved more than a ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: